Telemedicine: How to Find the Right Virtual Health Care

Video

Looking for the right virtual care can be important for patients with cancer, but now in the midst of the COVID-19 Pandemic, it’s essential. Here is one expert's advice for patients new to telemedicine.

As the COVID-19 pandemic continues to grip the country, more and more patients with cancer are relying on virtual health care, known as telemedicine, for everything from routine check-ups to the examination of worrisome symptoms.

CURE® recently spoke with Dr. Judd Hollander, associate dean for strategic health initiatives at Sidney Kimmel Medical College at Thomas Jefferson University, about how the tides are shifting in the field of telemedicine, making it easier for patients with cancer to get safe access to the care they need— even during a pandemic.

While his own system has been practicing telemedicine for some time now, Hollander went into the challenges that some patients with cancer might face when exploring their own virtual health care options during the pandemic and explained how individuals should weigh the pros and cons of each option.

Transcription:

I think the best thing to do is check with your health system and your doctor to see if telemedicine is offered. There are ways you can get telemedicine through some places like Teledoc that could see you, but that’s not continuous, chronic care, particularly for cancer patients. So, if that’s what you can do, great. But I would always start with trying to do it with your own doctor in your own health system.

If you can’t get your own doctor, maybe somebody else in your health system that has access to your medical records, or somebody else in your health system who knows where you can go to get an x-ray or a blood test; those are going to be the second best answers.

The third best answer is one of the national provider networks that are very competent, but they know nothing about you or possibly your local region.

So, I think telemedicine is available to anybody with a phone, but you need to know what’s best for you and how to access it.

Related Videos
Jessica McDade, B.S.N., RN, OCN, in an interview with CURE
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Dr. Nguyen, from Stanford Health, in an interview with CURE
Dr. Barzi in an interview with CURE
Related Content